Preface ......................................................... v
Contributors ................................................... ix
1 Chemical Probe Development Versus Drug Development ........... 1
Michael R. Jackson
2 Phosphatase High-Throughput Screening Assay Design and
Selection .................................................... 7
Eduard A. Sergienko
3 Multisystemic Functions of Alkaline Phosphatases ............ 27
René Buchet, José Luis Millán, and David Magne
4 Robotic Implementation of Assays: Tissue-Nonspecific
Alkaline Phosphatase (TNAP) Case Study ...................... 53
Thomas D.Y. Chung
5 Inhibitors of Tissue-Nonspecific Alkaline Phosphatase
(TNAP): From Hits to Leads .................................. 85
Peter Teriete, Anthony B. Pinkerton, and Nicholas
D.P. Cosford
6 A Method for Direct Assessment of Tissue-Nonspecific
Alkaline Phosphatase (TNAP) Inhibitors in Blood Samples .... 103
Eduard A. Sergienko, Qing Sun, and Chen-Ting Ma
7 Isolation and Characteristics of Matrix Vesicles ........... 115
René Buchet, Slawomir Pikula, David Magne, and Saïda
Mebarek
8 The Use of Tissue-Nonspecific Alkaline Phosphatase (TNAP)
and PHOSPHO1 Inhibitors to Affect Mineralization by
Cultured Cells ............................................. 125
Tina Kiffer-Moreira and Sonoko Narisawa
9 Modulators of Intestinal Alkaline Phosphatase .............. 135
Ekaterina V. Bobkova, Tina Kiffer-Moreira, and Eduard
A. Sergienko
10 New Activity Assays for ENPP1 with Physiological
Substrates ATP and ADP ..................................... 145
Chen-Ting Ma and Eduard A. Sergienko
11 Structure of Acid Phosphatases ............................. 155
César L. Araujo and Pirkko T. Vihko
12 Purification of Prostatic Acid Phosphatase (PAP) for
Structural and Functional Studies .......................... 167
Annakaisa M. Herrala, Ileana B. Quintero, and Pirkko
T. Vihko
13 Protein Tyrosine Phosphatases: Structure, Function, and
Implication in Human Disease ............................... 179
Lutz Tautz, David A. Critton, and Stefan Grotegut
14 High-Throughput Screening for Protein Tyrosine
Phosphatase Activity Modulators ............................ 223
Lutz Tautz and Eduard A. Sergienko
15 Evaluating Effects of Tyrosine Phosphatase Inhibitors
on T Cell Receptor Signaling ............................... 241
Souad Rahmouni, Laurence Delacroix, Wallace H. Liu, and
Lutz Tautz
16 Interactor-Guided Dephosphorylation by Protein
Phosphatase-1 .............................................. 271
Shannah Boens, Kathelijne Szekér, Aleyde Van Eynde, and
Mathieu Bollen
17 Structure, Regulation, and Pharmacological Modulation
of PP2A Phosphatases ....................................... 283
Caroline Lambrecht, Dorien Haesen, Ward Sents, Elitsa
Ivanova, and Veerle Janssens
Index ......................................................... 307
|